-
1.发明申请公开(公告)号：US20190262329A1
公开(公告)日：2019-08-29
申请号：US16406918
申请日：2019-05-08
发明人： Balazs ALBRECHT , Michael AVEN , Janine LAMAR
摘要： The disclosure relates to the field of medicine, in particular to the field of veterinary medicine. The disclosure specifically relates to muscarinic antagonists (including long acting muscarinic antagonists (LAMAs)) for the treatment of airway disease, such as pulmonary disease, preferably recurrent airway obstruction (RAO), summer pasture associated obstructive pulmonary disease (SPAOPD), and inflammatory airway disease (IAD) in animals, preferably equines such as horses.
-
公开(公告)号：US20210106685A1
公开(公告)日：2021-04-15
申请号：US17132038
申请日：2020-12-23
发明人： Michael AVEN , Balazs ALBRECHT , Benjamin FRANZMANN , Matthias HAUSMANN , Janine LAMAR , Ingo LANG
摘要： The disclosure relates to the field of medicine, in particular to the field of veterinary medicine. The disclosure relates to a pharmaceutical (medicament) formulation of glucocorticoids, especially ciclesonide or a pharmaceutically acceptable derivative thereof.
-
3.发明申请公开(公告)号：US20210106564A1
公开(公告)日：2021-04-15
申请号：US17131312
申请日：2020-12-22
发明人： Balazs ALBRECHT , Sven ANKE , Saskia KLEY , Stefan Johannes LEHNER , Marcus STARK , Anne Michelle TRAAS , Tanja Margrit ZIMMERING
IPC分类号： A61K31/4178 , A61K9/00 , A61P9/12 , A61K31/4184
摘要： A method is described for the prophylaxis or treatment of hypertension in a cat in need of such treatment. The method includes administration of a therapeutically effective amount of angiotensin II receptor 1 (AT-1) antagonist (sartan) to the cat, where the therapeutically effective amount of the sartan is administered in a daily dosage amount that is varied over a treatment period, the daily dosage amount of the sartan for a first period of time during the treatment period is 1.0 to 5.0 mg/kg of body weight, and the daily dosage amount of the sartan is decreased for a second period of time subsequent the first period of time during the treatment period.
-
公开(公告)号：US20180153907A1
公开(公告)日：2018-06-07
申请号：US15889307
申请日：2018-02-06
发明人： Balazs ALBRECHT , Michael AVEN , Janine LAMAR , Ingo LANG
CPC分类号： A61K31/58 , A61K9/0073 , A61K9/0078 , A61K9/008
摘要： Methods of treating airway diseases in equines include administering to an equine an effective amount of ciclesonide or a pharmaceutically acceptable salt thereof or a composition including ciclesonide or a pharmaceutically acceptable salt thereof.
-
公开(公告)号：US20150313918A1
公开(公告)日：2015-11-05
申请号：US14654009
申请日：2013-12-18
发明人： Balazs ALBRECHT , Michael AVEN , Janine LAMAR , Ingo LANG
CPC分类号： A61K31/58 , A61K9/0073 , A61K9/0078 , A61K9/008
摘要： The invention relates to the field of medicine, in particular to the field of veterinary medicine. The invention relates to glucocorticoids, especially ciclesonide or a pharmaceutically acceptable derivative thereof, for the treatment of airway disease in horses, such as pulmonary disease, preferably recurrent airway obstruction (RAO), Summer Pasture Associated Obstructive Pulmonary disease (SPAOPD), and inflammatory airway disease (IAD).
摘要翻译： 本发明涉及医学领域，特别涉及兽医领域。 本发明涉及用于治疗马中气道疾病的糖皮质激素，特别是环索奈德或其药学上可接受的衍生物，例如肺部疾病，优选复发性气道阻塞（RAO），夏季牧场相关阻塞性肺病（SPAOPD）和炎性气道 疾病（IAD）。
-
公开(公告)号：US20170079988A1
公开(公告)日：2017-03-23
申请号：US15292765
申请日：2016-10-13
发明人： Balazs ALBRECHT , Michael AVEN , Janine LAMAR , Ingo LANG
CPC分类号： A61K31/58 , A61K9/0073 , A61K9/0078 , A61K9/008
摘要： The invention relates to the field of medicine, in particular to the field of veterinary medicine. The invention relates to glucocorticoids, especially ciclesonide or a pharmaceutically acceptable derivative or salt thereof, for the treatment of airway disease in horses, such as pulmonary disease, preferably recurrent airway obstruction (RAO), Summer Pasture Associated Obstructive Pulmonary disease (SPAOPD), and inflammatory airway disease (IAD).
-
7.发明申请MUSCARINIC ANTAGONISTS AND COMBINATIONS THEREOF FOR THE TREATMENT OF AIRWAY DISEASE IN HORSES 审中-公开用于治疗马齿苋病的麻醉药拮抗剂及其组合公开(公告)号：US20170007593A1
公开(公告)日：2017-01-12
申请号：US15274259
申请日：2016-09-23
发明人： Balazs ALBRECHT , Michael AVEN , Janine LAMAR
CPC分类号： A61K31/46 , A61K9/0073 , A61K9/008 , A61K31/58 , A61K35/06 , A61K45/06 , A61M15/009 , A61M2250/00 , A61K2300/00
摘要： The invention relates to the field of medicine, in particular to the field of veterinary medicine. The invention specifically relates to muscarinic antagonists (including long acting muscarinic antagonists (LAMAs)) for the treatment of airway disease, such as pulmonary disease, preferably recurrent airway obstruction (RAO), summer pasture associated obstructive pulmonary disease (SPAOPD), and inflammatory airway disease (IAD) in animals, preferably equines such as horses.
摘要翻译： 本发明涉及医学领域，特别涉及兽医领域。 本发明具体涉及毒蕈碱拮抗剂（包括长效毒蕈碱拮抗剂（LAMAs）），用于治疗气道疾病，例如肺部疾病，优选复发性气道阻塞（RAO），夏季牧场相关阻塞性肺病（SPAOPD）和炎性气道 动物中的疾病（IAD），优选马，如马。
-
公开(公告)号：US20230033224A1
公开(公告)日：2023-02-02
申请号：US17758427
申请日：2021-01-06
摘要： The invention relates to ciclesonide or a pharmaceutically acceptable salt thereof or a composition comprising ciclesonide or a pharmaceutically acceptable salt thereof for the use in a method of ameliorating quality of life (QOL) in equines, preferably horses.
-
9.发明申请公开(公告)号：US20190008831A1
公开(公告)日：2019-01-10
申请号：US16027422
申请日：2018-07-05
发明人： Balazs ALBRECHT , Sven ANKE , Saskia KLEY , Stefan Johannes LEHNER , Marcus STARK , Anne Michelle TRAAS , Tanja Margrit ZIMMERING
IPC分类号： A61K31/4178 , A61P9/12 , A61K9/00
摘要： A method is described for the prophylaxis or treatment of hypertension in a cat in need of such treatment. The method includes administration of a therapeutically effective amount of angiotensin II receptor 1 (AT-1) antagonist (sartan) to the cat, where the therapeutically effective amount of the sartan is administered in a daily dosage amount that is varied over a treatment period, the daily dosage amount of the sartan for a first period of time during the treatment period is 1.0 to 5.0 mg/kg of body weight, and the daily dosage amount of the sartan is decreased for a second period of time subsequent the first period of time during the treatment period.
-
10.发明申请公开(公告)号：US20150366855A1
公开(公告)日：2015-12-24
申请号：US14740582
申请日：2015-06-16
发明人： Balazs ALBRECHT , Michael AVEN , Janine LAMAR
CPC分类号： A61K31/46 , A61K9/0073 , A61K9/008 , A61K31/58 , A61K35/06 , A61K45/06 , A61M15/009 , A61M2250/00 , A61K2300/00
摘要： The invention relates to the field of medicine, in particular to the field of veterinary medicine. The invention specifically relates to muscarinic antagonists (including long acting muscarinic antagonists (LAMAs)) for the treatment of airway disease, such as pulmonary disease, preferably recurrent airway obstruction (RAO), summer pasture associated obstructive pulmonary disease (SPAOPD), and inflammatory airway disease (IAD) in animals, preferably equines such as horses.
摘要翻译： 本发明涉及医学领域，特别涉及兽医领域。 本发明具体涉及毒蕈碱拮抗剂（包括长效毒蕈碱拮抗剂（LAMAs）），用于治疗气道疾病，例如肺部疾病，优选复发性气道阻塞（RAO），夏季牧场相关阻塞性肺病（SPAOPD）和炎性气道 动物中的疾病（IAD），优选马，如马。
-
-
-
-
-
-
-
-
-
搜索结果
10 条记录 (耗时 0.022 秒)
